314 pending office actions • 201 clients
| App # | Title | Client | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|---|
| 19344208 | Untitled | R7 Instruments, Inc. | LARGI, MATTHEW THOMAS | 3746 | Non-Final OA | |
| 19004913 | Untitled | Oxipital AI Inc. | ROBARGE, TYLER ROGER | 3658 | Non-Final OA | |
| 19397828 | Untitled | Perfuse Therapeutics, Inc. | BASQUILL, SEAN M | 1614 | Non-Final OA | |
| 19176666 | Untitled | Recentive Analytics, Inc. | MONTOYA, OSCHTA I | 2421 | Non-Final OA | |
| 19338730 | Untitled | Teikoku Pharma Usa, Inc. | HAVLIN, ROBERT H | 1626 | Non-Final OA | |
| 19186007 | Untitled | Sertainty Corporation | QAYYUM, ZESHAN | 3697 | Non-Final OA | |
| 19376486 | Untitled | Grin Therapeutics, Inc. | RODRIGUEZ, RAYNA B | 1628 | Non-Final OA | |
| 19348728 | Untitled | Aspire Biopharma Holdings, Inc. | SONG, JIANFENG | 1613 | Non-Final OA | |
| 19022649 | Untitled | BEIJING SUPERSTRING ACADEMY OF MEMORY TECHNOLOGY | TALBOT, BRIAN K | 1712 | Non-Final OA | |
| 19207675 | Untitled | Estellejoylynn, LLC | SENGUPTA, SONYA MAZUMDAR | 1745 | Non-Final OA | |
| 19283716 | AFFINITY MATURED ANTI-OX40 ANTIBODIES AND USE THEREOF | Ichnos Sciences SA | WEIDNER, ADAM M | 1675 | Non-Final OA | Jul 29, 2025 |
| 19284259 | SYSTEMS AND METHODS FOR DENTAL TREATMENT WITH EKF | T33 Dental, Inc. | GONZALEZ, LEI NMN | 3783 | Non-Final OA | Jul 29, 2025 |
| 19272338 | MICROFLUIDIC DEVICES FOR HIGH THROUGHPUT SCREENING OF CELL-CELL INTERACTIONS | Shennon Biotechnologies Inc. | GORDON, BRIAN R | 1798 | Non-Final OA | Jul 17, 2025 |
| 19250513 | NASAL IRRIGATION DEVICE AND SYSTEM WITH FAUX COLLAPSIBLE CARTRIDGE ELEMENT | Rhinosystems, Inc. | IMPINK, MOLLIE LLEWELLYN | 3799 | Final Rejection | Jun 26, 2025 |
| 19249949 | EXHAUST PLENUM SYSTEM AND METHODS FOR A VENTILATION SYSTEM | Unknown | ZERPHEY, CHRISTOPHER R | 3799 | Non-Final OA | Jun 25, 2025 |
| 19232766 | APPARATUS AND METHOD FOR SOLID PHASE EXTRACTION | GE Healthcare Limited | SCHLIENTZ, LEAH H | 1618 | Final Rejection | Jun 09, 2025 |
| 19232774 | METHOD FOR PREPARING AN [18F] RADIOLABELLED COMPOUND WITH LOW WATER CONTENT DURING LABELLING STEP | GE Healthcare, Inc. | SCHLIENTZ, LEAH H | 1618 | Final Rejection | Jun 09, 2025 |
| 19230889 | AN IMPROVED PROCESS OF PURIFICATION OF PROTEIN | Kashiv Biosciences, LLC | MCDERMOTT, JEANNIE | 1777 | Final Rejection | Jun 06, 2025 |
| 19230884 | AN IMPROVED PROCESS OF PURIFICATION OF PROTEIN | Kashiv Biosciences, LLC | MCDERMOTT, JEANNIE | 1777 | Final Rejection | Jun 06, 2025 |
| 19197571 | SYSTEMS AND METHODS FOR DATA STRUCTURE ANALYSIS | Gestalt Tech Corp. | SAMARA, HUSAM TURKI | 2161 | Non-Final OA | May 02, 2025 |
| 19190529 | IMMEDIATE RELEASE MULTILAYER TABLET | Alkermes Pharma Ireland Limited | TRAN, SUSAN T | 1615 | Final Rejection | Apr 25, 2025 |
| 19171169 | METHODS OF USING RADIPRODIL IN THE TREATMENT OF DISORDERS | Grin Therapeutics, Inc. | TRAN, SUSAN T | 1615 | Final Rejection | Apr 04, 2025 |
| 19004969 | LOGGING AND ANALYZING ROBOTIC PICKING DATA | Oxipital AI Inc. | NELESKI, ELIZABETH ROSE | 3658 | Non-Final OA | Dec 30, 2024 |
| 19004904 | FILTERING AND SORTING OBJECTS IN A ROBOTIC PICKING SYSTEM | Oxipital AI Inc. | TRAN, ALYSE TRAMANH | 3656 | Non-Final OA | Dec 30, 2024 |
| 18978570 | APPARATUS AND METHOD FOR INTERACTIVE PLATFORM ACCESS AUTHORIZATION | Kidentify Pte. Ltd. | MCCULLOCH JR, WILLIAM H | 3715 | Final Rejection | Dec 12, 2024 |
| 18972007 | PROCESS OF AFFINITY CHROMATOGRAPHY | Kashiv Biosciences, LLC | NORRIS, CLAIRE A | 1779 | Non-Final OA | Dec 06, 2024 |
| 18962320 | SYSTEMS AND METHODS FOR CYBERSECURITY RISK MITIGATION AND MANAGEMENT | Bitsight Technologies, Inc. | LEUNG, ROBERT B | 2494 | Non-Final OA | Nov 27, 2024 |
| 18957201 | APPARATUS AND METHOD FOR MOBILE APPLICATION ENCRYPTION | Sertainty Corporation | NGUYEN, CAROLINE HOANG-ANH | 2495 | Non-Final OA | Nov 22, 2024 |
| 18926965 | FORMULATION OF HIGHLY CONCENTRATED PHARMACOLOGICALLY ACTIVE ANTIBODY | Kashiv Biosciences, LLC | TAYLOR, LIA ELAN | 1641 | Final Rejection | Oct 25, 2024 |
| 18917288 | SYSTEM, METHOD AND INTERFACE FOR PARALLEL PROCESSING OF ANTIMICROBIAL SUSCEPTIBILITY TESTS USING DIFFERENT SAMPLES | Selux Diagnostics, Inc. | LAU, HOI CHING | 2689 | Non-Final OA | Oct 16, 2024 |
| 18909461 | WEARABLE COMPUTER POINTING APPARATUS | 6Degrees Ltd. | LEIBY, CHRISTOPHER E | 2621 | Final Rejection | Oct 08, 2024 |
| 18886015 | SYSTEMS AND METHODS FOR NONLINEAR VIDEO PLAYBACK USING LINEAR REAL-TIME VIDEO PLAYERS | Jbf Interlude 2009 Ltd. | DOSHI, AKSHAY | 2422 | Non-Final OA | Sep 16, 2024 |
| 18885235 | NANOSENSORS AND USE THEREOF | Nanomosaic Inc. | XING, CHRISTINA ILONA | 2877 | Non-Final OA | Sep 13, 2024 |
| 18799908 | SYSTEMS AND METHODS FOR DETERMINING EVENT SCHEDULES | Recentive Analytics, Inc. | KNIGHT, LETORIA G | 3623 | Final Rejection | Aug 09, 2024 |
| 18793396 | METHOD FOR NUCLEAR GENOME EDITING USING PLASTID SELECTABLE MARKERS | Phykion Inc. | ORDAZ, CHRISTIAN JOSE | 1663 | Non-Final OA | Aug 02, 2024 |
| 18786359 | SYSTEM AND METHOD OF REMOTE REHABILITATION THERAPY FOR MOVEMENT DISORDERS | Encora, Inc. | YIP, JACK | 3715 | Non-Final OA | Jul 26, 2024 |
| 18770949 | SYSTEMS AND METHODS FOR ASSESSING CYBERSECURITY RISK IN A WORK FROM HOME ENVIRONMENT | Bitsight Technologies, Inc. | FAROOQUI, QUAZI | 2491 | Non-Final OA | Jul 12, 2024 |
| 18746530 | PULMONARY ARTERIAL COMPLIANCE ENHANCEMENT AND CONTROL DEVICE | Corvia Medical, Inc. | RABAGLIA, BRIDGET ELIZABETH | 3771 | Non-Final OA | Jun 18, 2024 |
| 18720877 | AN IMPROVED METHOD FOR SEPARATION OF LOW MOLECULAR WEIGHT PROTEINS | Kashiv Biosciences, LLC | NOGUEROLA, ALEXANDER STEPHAN | 1795 | Non-Final OA | Jun 17, 2024 |
| 18735600 | OCULAR FORMULATIONS FOR DRUG-DELIVERY TO THE POSTERIOR SEGMENT OF THE EYE | Panoptica, Inc. | HAVLIN, ROBERT H | 1626 | Non-Final OA | Jun 06, 2024 |
| 18678378 | SYSTEMS AND METHODS FOR PREDICTING CYBERSECURITY RISK BASED ON ENTITY FIRMOGRAPHICS | Bitsight Technologies, Inc. | NAHAR, SAYEDA S | 2435 | Non-Final OA | May 30, 2024 |
| 18675958 | CD71 BINDING FIBRONECTIN TYPE III DOMAINS | Aro Biotherapeutics | DABKOWSKI, ERINNE R | 1654 | Non-Final OA | May 28, 2024 |
| 18659379 | SYSTEM AND METHOD FOR TREATMENT OF PERIODONTIC POCKETS USING DISPOSABLE INSERTS | Convergent Dental, Inc. | MORAN, EDWARD JOHN | 3772 | Non-Final OA | May 09, 2024 |
| 18657920 | PROCESS FOR PREPARATION OF STABLE PROTEIN SOLUTION | Kashiv Biosciences, LLC | HUANG, RYAN | 1777 | Non-Final OA | May 08, 2024 |
| 18251079 | MODULATORS OF THE INTEGRATED STRESS PATHWAY | AbbVie Inc. | RAO, PADMAJA S | 1627 | Non-Final OA | Apr 28, 2024 |
| 18642140 | METHOD AND SYSTEM FOR CONSISTENT, REPEATABLE, AND SAFE CRYOSPRAY TREATMENT OF AIRWAY TISSUE | Csa Medical, Inc. | PEFFLEY, MICHAEL F | 3794 | Non-Final OA | Apr 22, 2024 |
| 18632996 | METHODS OF MAKING BEMPEDOIC ACID AND COMPOSITIONS OF THE SAME | Esperion Therapeutics, Inc. | MURESAN, ANA Z | 1692 | Non-Final OA | Apr 11, 2024 |
| 18626908 | SYSTEMS AND METHODS FOR VARIABLY SCOPED, DATA-DEPENDENT READ SNAPSHOTS | Cockroach Labs, Inc. | MAY, ROBERT F | 2154 | Final Rejection | Apr 04, 2024 |
| 18697203 | ENGINEERED LIPASE ENZYMES, MANUFACTURE AND USE THEREOF | Anagram Therapeutics, Inc. | SELWANES, JOHN PAUL | 1651 | Non-Final OA | Mar 29, 2024 |
| 18620255 | PROCESS FOR PURIFICATION OF FUSION PROTEIN | Kashiv Biosciences, LLC | KIM, YUNSOO | 1641 | Non-Final OA | Mar 28, 2024 |
| 18696701 | AN IMPROVED PROCESS FOR PURIFICATION OF FUSION PROTEIN | Kashiv Biosciences, LLC | KINGDON, CATHY | 1663 | Non-Final OA | Mar 28, 2024 |
| 18614199 | VARIANT IgG FC POLYPEPTIDES AND USES THEREOF | Seismic Therapeutic, Inc. | ROONEY, NORA MAUREEN | 1641 | Non-Final OA | Mar 22, 2024 |
| 18612960 | Bispecific Asymmetric Heterodimers Comprising Anti-CD3 Constructs | Zymeworks, Inc. | HUYNH, PHUONG N | 1641 | Non-Final OA | Mar 21, 2024 |
| 18599632 | PAIN TREATMENT FORMULATIONS AND METHODS OF USING THE SAME | Unknown | SHIM, DAVID M. | 1626 | Non-Final OA | Mar 08, 2024 |
| 18598289 | PRODUCTION OF HEPATOCYTES | Cambridge Enterprise Limited (Gb/Gb) | BABIC, CHRISTOPHER M | 1633 | Non-Final OA | Mar 07, 2024 |
| 18593643 | INDOLE COMPOUNDS AND METHODS OF USE | Genzyme Corporation | HEASLEY, MEGHAN CHRISTINE | 1626 | Non-Final OA | Mar 01, 2024 |
| 18683423 | METHODS AND COMPOSITIONS FOR TREATING HYPERGLYCEMIA AND DIABETES | Anagram Therapeutics, Inc. | EIX, EMILY FAY | 1653 | Non-Final OA | Feb 13, 2024 |
| 18437558 | SUBSTITUTED PYRAZOLO[1,5-A]PYRIMIDINES AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS | Bial - R&D Investments, S.A. | COLEMAN, BRENDA LIBBY | 1624 | Final Rejection | Feb 09, 2024 |
| 18436111 | CONTROLLED RELEASE TOPICAL TESTOSTERONE FORMULATIONS AND METHODS | Acerus Biopharma Inc. | ROMERO, KRISTEN WANG | 1624 | Non-Final OA | Feb 08, 2024 |
| 18681694 | MULTI MODALITY ROTARY OPTICAL SYSTEMS AND METHODS OF THEIR USE | Koninklijke Philips N.V. | BOLOGNA, DOMINIC JOSEPH | 2877 | Non-Final OA | Feb 06, 2024 |
| 18294893 | PHRENIC NERVE PACING DEVICE | Texas Heart Institute | SAHAND, SANA | 3796 | Non-Final OA | Feb 02, 2024 |
| 18681014 | ANALYTIC METHOD AND DEVICE FOR QUANTITATIVELY CALCULATING LINE EDGE ROUGHNESS IN PLASMA ULTRA-DIFFRACTION PHOTOETCHING PROCESS | Institute Of Microelectronics, Chinese Academy Of Sciences | WHITESELL, STEVEN H | 1759 | Non-Final OA | Feb 02, 2024 |
| 18429539 | SYSTEMS AND METHODS FOR INFERRING ENTITY RELATIONSHIPS VIA NETWORK COMMUNICATIONS OF USERS OR USER DEVICES | Bitsight Technologies, Inc. | RANDHAWA, MANDISH K | 2477 | Non-Final OA | Feb 01, 2024 |
| 18294510 | A PHARMACEUTICAL COMBINATION AND USE THEREOF | Ascentage Pharma Group Corp Limited | OH, TAYLOR V | 1625 | Non-Final OA | Feb 01, 2024 |
| 18425439 | MULTI-MATERIAL FIBERS AND METHODS OF MANUFACTURING THE SAME | Massachusetts Institute Of Technology | LEE, SEUNG H | 2876 | Non-Final OA | Jan 29, 2024 |
| 18292603 | METHODS FOR SELECTING ANTIMICROBIALS AGAINST PHYTOPATHOGENS | Organicin Scientific, Inc. | ARIANI, KADE | 1651 | Non-Final OA | Jan 26, 2024 |
| 18421551 | DERIVATIZED CHITOSAN POLYMERS AND METHODS OF TREATING VASCULAR DISORDERS | Synedgen, Inc. | LAU, JONATHAN S | 1693 | Final Rejection | Jan 24, 2024 |
| 18416440 | DEVICES AND METHODS FOR TREATING HEART FAILURE | Corvia Medical, Inc. | YANG, CHENG FONG | 3781 | Non-Final OA | Jan 18, 2024 |
| 18580024 | METHODS OF TREATING FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY WITH LOSMAPIMOD | Fulcrum Therapeutics, Inc. | SHIM, DAVID M. | 1626 | Non-Final OA | Jan 17, 2024 |
| 18410464 | NON-NANOPARTICULATE APPLICATION FORMS OF MACROLIDES | Nucleus Medical GmbH | LEE, SIN J | 1613 | Final Rejection | Jan 11, 2024 |
| 18406499 | SYSTEMS AND METHODS FOR IMAGE PRIVACY | Xailient | JACKSON, JENISE E | 2499 | Non-Final OA | Jan 08, 2024 |
| 18576065 | PATHOGEN TESTING DEVICE | Rt Microfluidics, Inc. | NOAKES, SUZANNE MARIE | 1656 | Non-Final OA | Jan 02, 2024 |
| 18572741 | Degrader Compounds and Uses Thereof | AbbVie Inc. | SHIAO, REI TSANG | 1691 | Non-Final OA | Dec 20, 2023 |
| 18543249 | Controllable Transcription | Cambridge Enterprise Limited (Gb/Gb) | KONOPKA, CATHERINE ANNE | 1635 | Non-Final OA | Dec 18, 2023 |
| 18543652 | SEMICONDUCTOR DEVICE AND METHOD FOR MANUFACTURING THE SAME | Institute Of Microelectronics, Chinese Academy Of Sciences | LEE, KYOUNG | 2817 | Non-Final OA | Dec 18, 2023 |
| 18570958 | GELLAN GUM COMPOSITIONS AND METHOD FOR THEIR PREPARATION | Auregen Biotherapeutics SA | HEASLEY, MEGHAN CHRISTINE | 1626 | Non-Final OA | Dec 15, 2023 |
| 18571170 | SYSTEMS AND METHODS FOR INTERRUPTING NERVE ACTIVITY TO TREAT A MEDICAL CONDITION | Texas Medical Center | FLANAGAN, BEVERLY MEINDL | 3794 | Non-Final OA | Dec 15, 2023 |
| 18570579 | Self-Assembling Nanoparticles Based On Amphiphilic Peptides for Drug Delivery Applications | The United States Department of Health and Human Services | DAVIS, BRIAN J | 1614 | Non-Final OA | Dec 14, 2023 |
| 18537700 | INHIBITORS OF CANCER INVASION, ATTACHMENT, AND/OR METASTASIS | Sanford Burnham Prebys Medical Discovery Institute | LEESER, ERICH A | 1622 | Non-Final OA | Dec 12, 2023 |
| 18535441 | METHOD, SYSTEM, AND APPARATUS FOR ANALYZING AN ANALYTE OF A SINGLE CELL | Mission Bio, Inc. | SALMON, KATHERINE D | 1682 | Non-Final OA | Dec 11, 2023 |
| 18535291 | HETEROCYCLIC MODULATORS OF LIPID SYNTHESIS | Sagimet Biosciences Inc. | BORALSKY, LUKE ALAN | 1624 | Final Rejection | Dec 11, 2023 |
| 18568694 | NON-NANOPARTICULATE APPLICATION FORMS OF MACROLIDES | Nucleus Medical GmbH | MERCIER, MELISSA S | 1615 | Non-Final OA | Dec 08, 2023 |
| 18533891 | GATE-ALL-AROUND TRANSISTOR AND METHOD FOR MANUFACTURING THE SAME | Institute Of Microelectronics, Chinese Academy Of Sciences | CLINTON, EVAN GARRETT | 2899 | Non-Final OA | Dec 08, 2023 |
| 18532424 | Papain-like protease (PLpro) inhibitors | Pfizer, Inc. | BELL, SARA ELIZABETH | 1625 | Non-Final OA | Dec 07, 2023 |
| 18518255 | ROTATOR CUFF SYSTEM AND METHODS THEREOF | Anika Therapeutics, Inc. | DANG, PHONG SON H | 3771 | Non-Final OA | Nov 22, 2023 |
| 18514333 | RARE NUCLEIC ACID DETECTION | Harbinger Health, Inc. | WOOLWINE, SAMUEL C | 1681 | Non-Final OA | Nov 20, 2023 |
| 18512575 | 2,6-DICHLOROPHENYL ESTER COMPOUNDS AND USE THEREOF | Fusion Pharmaceuticals Inc. | YOO, SUN JAE | 1621 | Non-Final OA | Nov 17, 2023 |
| 18504390 | AUTOMATIC POST-PRODUCTION FOR PRODUCT VIDEOS | Jbf Interlude 2009 Ltd. | CHOWDHURY, SUMAIYA A | 2421 | Non-Final OA | Nov 08, 2023 |
| 18504790 | METHODS AND SYSTEMS FOR NON-BLOCKING TRANSACTIONS | Cockroach Labs, Inc. | FILIPCZYK, MARCIN R | 2153 | Final Rejection | Nov 08, 2023 |
| 18559755 | METHOD FOR PREPARING RESERVOIR ELEMENT | Institute Of Microelectronics, Chinese Academy Of Sciences | LEE, EUGENE | 2815 | Non-Final OA | Nov 08, 2023 |
| 18503723 | Microfluidic Devices for High Throughput Screening of Cell-Cell Interactions | Shennon Biotechnologies Inc. | CORDAS, EMILY ANN | 1632 | Non-Final OA | Nov 07, 2023 |
| 18559185 | EXATECAN DERIVATIVES AND ANTIBODY-DRUG CONJUGATES THEREOF | Alx Oncology Inc. | COUGHLIN, MATTHEW P | 1626 | Non-Final OA | Nov 06, 2023 |
| 18502867 | EXPLAINABLE AI (XAI) PLATFORM FOR COMPUTATIONAL PATHOLOGY | Spintellx, Inc. | GEBRESLASSIE, WINTA | 2677 | Non-Final OA | Nov 06, 2023 |
| 18501307 | 4-AMINOPYRROLO[2,1-F][1,2,4]TRIAZINES AND PREPARATION AND USES THEREOF | Biosplice Therapeutics, Inc. | SHIAO, REI TSANG | 1691 | Non-Final OA | Nov 03, 2023 |
| 18558139 | PYRIDINO-OR PYRIMIDO-CYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF | Zhejiang Genfleet Therapeutics Co., Ltd. | SHTERENGARTS, SAMANTHA L | 1623 | Non-Final OA | Oct 30, 2023 |
| 18557694 | METHODS OF REGULATING BCL11A EXPRESSION AND TREATMENT OF BCL11A-MEDIATED DISORDERS | Fulcrum Therapeutics, Inc. | LEE, ANDREW P | 1691 | Non-Final OA | Oct 27, 2023 |
| 18288741 | COMPOUNDS, COMPOSITIONS AND METHODS OF TREATING DISORDERS | Chengdu Anticancer Bioscience, Ltd. | SEITZ, ANTHONY JOSEPH | 1629 | Non-Final OA | Oct 27, 2023 |
| 18494545 | TREATMENT OF OCULAR DISEASES USING ENDOTHELIN RECEPTOR ANTAGONISTS | Perfuse Therapeutics, Inc. | HUANG, GIGI GEORGIANA | 1613 | Non-Final OA | Oct 25, 2023 |
| 18493030 | AUTOMATION COMPATIBLE COLLECTION DEVICE FOR BIOLOGICAL SAMPLES | Rhinostics Inc. | WESTFALL, SARAH ANN | 3791 | Non-Final OA | Oct 24, 2023 |
| 18491562 | SYSTEMS AND METHODS FOR DEVELOPMENT AND DEPLOYMENT OF CLOUD SERVICES | Opscanvas, Inc. | HU, SELINA ELISA | 2193 | Non-Final OA | Oct 20, 2023 |
| 18286966 | COMPOUNDS, COMPOSITIONS AND METHODS OF TREATING CANCER | Hotspot Therapeutics, Inc. | SEITZ, ANTHONY JOSEPH | 1629 | Non-Final OA | Oct 13, 2023 |
| 18555277 | POMACE LEACHATE HERBICIDE COMPOSITION AND METHODS | Jackson Family Wines, Inc. | PEEBLES, KATHERINE | 1617 | Non-Final OA | Oct 13, 2023 |
| 18485780 | ISOINDOLINONE AMIDE COMPOUNDS USEFUL TO TREAT DISEASES ASSOCIATED WITH GSPT1 | Monte Rosa Therapeutics AG | MCKOY, QUINCY ANDRE | 1626 | Non-Final OA | Oct 12, 2023 |
| 18485766 | ISOINDOLINONE COMPOUNDS | Monte Rosa Therapeutics AG | BARSKY, JARED | 1628 | Non-Final OA | Oct 12, 2023 |
| 18554232 | ANTI-INFLAMMATORY SIGLEC PROTEINS AND METHODS OF MAKING AND USING SAME | Palleon Pharmaceuticals Inc. | JOHANSEN, PETER N. | 1644 | Non-Final OA | Oct 06, 2023 |
| 18480274 | ROBOTIC SYSTEM FOR DELIVERING ENERGY TO AN ANATOMICAL ELEMENT | Csa Medical, Inc. | LANCASTER, LINDSAY REGAN | 3794 | Non-Final OA | Oct 03, 2023 |
| 18285369 | COMPACT PROMOTERS FOR GENE EXPRESSION | Hunterian Medicine LLC | HUDSON, AMY ROSE | 1636 | Non-Final OA | Oct 02, 2023 |
| 18553317 | MACROCYCLIC AZOLOPYRIDINES | Fulcrum Therapeutics, Inc. | KENYON, JOHN S | 1625 | Non-Final OA | Sep 29, 2023 |
| 18553352 | POLYMORPHIC FORMS OF (S)-12-FLUORO-4-(1-METHYL-1H-PYRAZOL-5-YL)-7A,8,13,14-TETRAHYDRO-7H-[1,2,4]TRIAZOLO[4',3':1,6]PYRIDO[3,2-B]BENZOFURO[4,3-FG][1,4]OXAZONINE | Fulcrum Therapeutics, Inc. | HAVLIN, ROBERT H | 1626 | Non-Final OA | Sep 29, 2023 |
| 17995096 | APPLICATIONS OF P14K INHIBITOR IN INTRACELLULAR PROTEIN MISFOLDING-RELATED DISEASES AND LYSOSOMAL STORAGE DISEASES | Nuo-Beta Pharmaceutical Technology (Shanghai) Co., Ltd. | CHONG, YONG SOO | 1623 | Non-Final OA | Sep 28, 2023 |
| 18477504 | HIGH PURITY COPPER RADIOPHARMACEUTICAL COMPOSITIONS AND DIAGNOSTIC AND THERAPEUTIC USES THEREOF | University of Basel | PERREIRA, MELISSA JEAN | 1618 | Non-Final OA | Sep 28, 2023 |
| 18475792 | HIGH PRODUCTIVITY ALGAL MUTANTS HAVING REDUCED PHOTOSYNTHETIC ANTENNA | Phykion Inc. | KALLIS, RUSSELL | 1663 | Non-Final OA | Sep 27, 2023 |
| 18476006 | APPLICATION DATA PROTECTION METHOD AND SYSTEM | Trilio Data, Inc. | TRUONG, LOAN | 2114 | Final Rejection | Sep 27, 2023 |
| 18474211 | SOLID TARGET SYSTEMS FOR THE PRODUCTION OF HIGH-PURITY RADIONUCLIDE COMPOSITIONS | Nuclidium AG | CRAIG, KAILA ANGELIQUE | 1618 | Non-Final OA | Sep 25, 2023 |
| 18552070 | A STABLE, EMULSION-FORMING LIQUID COMPOSITION COMPRISING AMINO ACIDS | Brainluxury Inc. | YOO, HONG THI | 1792 | Non-Final OA | Sep 22, 2023 |
| 18471563 | PHARMACEUTICAL COMPOSITIONS FOR USE IN THE PREVENTION AND TREATMENT OF A DISEASE OR DISORDER CAUSED BY OR ASSOCIATED WITH ONE OR MORE PREMATURE TERMINATION CODONS | Monte Rosa Therapeutics AG | HASTINGS, ALISON AZAR | 1627 | Non-Final OA | Sep 21, 2023 |
| 18369521 | Application Of PI4KIIIA Protein And Related Membrane Protein Complex In Treating Alzheimer's Disease | Jiangsu Nuo-Beta Pharmaceutical Technology Co., Ltd. | WEIDNER, ADAM M | 1675 | Non-Final OA | Sep 18, 2023 |
| 18468506 | DOSING REGIMENS FOR HEMATOPOIETIC STEM CELL MOBILIZATION FOR STEM CELL TRANSPLANTS IN MULTIPLE MYELOMA PATIENTS | Ensoma, Inc. | PAGONAKIS, ANNA | 6221 | Non-Final OA | Sep 15, 2023 |
| 18282254 | PYRIMIDINE-FUSED CYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF | Zhejiang Genfleet Therapeutics Co., Ltd. | HEASLEY, MEGHAN CHRISTINE | 1626 | Non-Final OA | Sep 15, 2023 |
| 18463456 | TECHNIQUES FOR IDENTIFYING OPTIMAL EV CHARGING STATION LOCATIONS | Recentive Analytics, Inc. | NGUYEN, NGA X | 3662 | Final Rejection | Sep 08, 2023 |
| 18462918 | MODULATORS OF THE INTEGRATED STRESS PATHWAY | AbbVie Inc. | NOLAN, JASON MICHAEL | 1623 | Final Rejection | Sep 07, 2023 |
| 18549452 | STABILIZED LIQUID COMPOSITIONS COMPRISING A LEVODOPA-TYROSINE CONJUGATE AND USES THEREOF | Neuroderm, Ltd. | CHO, DAVID H | 1693 | Non-Final OA | Sep 07, 2023 |
| 18461179 | INHIBITORS OF CYSTEINE PROTEASES AND METHODS OF USE THEREOF | Pardes Biosciences, Inc. | MCDOWELL, BRIAN E | 1624 | Final Rejection | Sep 05, 2023 |
| 18242470 | Covalent Binding Compounds for the Treatment of Disease | Hyku Biosciences Inc. | KENYON, JOHN S | 1625 | Non-Final OA | Sep 05, 2023 |
| 18242466 | COVALENT CDK2-BINDING COMPOUNDS FOR THERAPEUTIC PURPOSES | Hyku Biosciences Inc. | NOLAN, JASON MICHAEL | 1623 | Non-Final OA | Sep 05, 2023 |
| 18279938 | ENHANCED TARGETING USING ANTIBODY-OLIGONUCLEOTIDE CONJUGATES | UNIVERSITY OF MARYLAND, BALTIMORE | NICKOL, GARY B | 1643 | Non-Final OA | Sep 01, 2023 |
| 18459236 | THE NOVEL MONOCLONAL ANTIBODIES TO PROGRAMMED DEATH 1 (PD-1) | Cstone Pharmaceuticals (Shanghai) Co., Ltd. | LU, CHENG | 1642 | Final Rejection | Aug 31, 2023 |
| 18240823 | DEVICES FOR COLLECTING CAPILLARY BLOOD AND METHODS FOR SAME | Paulus Holdings Limited | PORTILLO, JAIRO H | 3791 | Non-Final OA | Aug 31, 2023 |
| 18240138 | ORTHOPEDIC ATTACHMENT SYSTEMS AND METHODS THEREOF | Anika Therapeutics, Inc. | ROGERS, JAMES WILLIAM | 1618 | Non-Final OA | Aug 30, 2023 |
| 18546312 | PYRROLO[3,2-D]PYRIMIDINE COMPOUNDS AND METHODS OF USE IN THE TREATMENT OF CANCER | Tango Therapeutics, Inc. | NOLAN, JASON MICHAEL | 1623 | Non-Final OA | Aug 14, 2023 |
| 18277220 | Self-Assembling Nanoparticles Based On Amphiphilic Peptides | The United States Department of Health and Human Services | VARADARAJ, ARCHANA | 1658 | Non-Final OA | Aug 14, 2023 |
| 18448385 | APPARATUS AND METHOD FOR REDUCTION OF NEUROLOGICAL MOVEMENT DISORDER SYMPTOMS USING WEARABLE DEVICE | Encora, Inc. | RAUBENSTRAW, TYLER ALLEN | 3785 | Non-Final OA | Aug 11, 2023 |
| 18448842 | COMPOSITIONS AND METHODS RELATED TO IMMUNOGLOBULIN PROTEASES AND FUSIONS THEREOF | Cartesian Therapeutics, Inc. | ALFANO, ALAN | 1641 | Non-Final OA | Aug 11, 2023 |
| 18228870 | METHODS AND COMPOSITIONS FOR TREATING DISORDERS ASSOCIATED WITH BILE ACIDS | Novome Biotechnologies, Inc. | JACKSON-TONGUE, LAKIA J | 1645 | Non-Final OA | Aug 01, 2023 |
| 18362326 | Apparatus and Method for Operating System Agnostic Data Encryption | Sertainty Corporation | ALATA, AYOUB | 2494 | Final Rejection | Jul 31, 2023 |
| 18362449 | DEVICES AND METHODS FOR PUNCTURING A CAPSULE TO RELEASE A POWDERED MEDICAMENT THEREFROM | Civitas Therapeutics, Inc. | PHILIPS, BRADLEY H | 3799 | Non-Final OA | Jul 31, 2023 |
| 18361571 | GENE THERAPY VECTORS FOR TREATING HEART DISEASE | Tenaya Therapeutics, Inc. | BERTOGLIO, VALARIE E | 1632 | Non-Final OA | Jul 28, 2023 |
| 18360533 | METHODS FOR THE TREATMENT OF CHILDHOOD-ONSET FLUENCY DISORDER | Noema Pharma AG | RAO, SAVITHA M | 1691 | Non-Final OA | Jul 27, 2023 |
| 18274511 | PLASMA KALLIKREIN ANTIBODIES AND USES THEREOF | Astria Therapeutics, Inc. | CHHAY, BONIRATH | 1645 | Non-Final OA | Jul 27, 2023 |
| 18263217 | MULTABODY CONSTRUCTS, COMPOSITIONS, AND METHODS | The Hospital for Sick Children | XIAO, YAN | 1642 | Non-Final OA | Jul 27, 2023 |
| 18359183 | SYSTEMS AND METHODS FOR ASSESSING CYBERSECURITY EFFICACY OF ENTITIES AGAINST COMMON CONTROL AND MATURITY FRAMEWORKS USING EXTERNALLY-OBSERVED DATASETS | Bitsight Technologies, Inc. | HAJIABBASI, AMIR MAHDI | 2407 | Final Rejection | Jul 26, 2023 |
| 18356925 | TISSUE PENETRATING AND BIODEGRADABLE DRUG DELIVERY DEVICES AND METHODS OF USE THEREOF | Panther Therapeutics, Inc. | GOTFREDSON, GAREN | 1619 | Non-Final OA | Jul 21, 2023 |
| 18262318 | METHOD FOR SIZE BASED EVALUATION OF PANCREATIC PROTEIN MIXTURE | Kashiv Biosciences, LLC | ROBINSON, HOPE A | 1652 | Non-Final OA | Jul 20, 2023 |
| 18355913 | HIGH MOLYBDENUM DUPLEX STAINLESS STEEL | Carpenter Technology Corporation | HILL, STEPHANI A | 1735 | Non-Final OA | Jul 20, 2023 |
| 18262069 | METHODS FOR OPTIMIZING REPRODUCTIVE TISSUE DERIVED CELL YIELD AND VIABILITY FOR CLINICAL APPLICATIONS | Gallant Pet. Inc. | MATALKAH, FATIMAH KHALAF | 1638 | Non-Final OA | Jul 19, 2023 |
| 18354193 | MODIFIED ALPHAVIRUS VECTORS | Gritstone Bio, Inc. | THUESON, HANNA MARIE | 1638 | Non-Final OA | Jul 18, 2023 |
| 18271924 | COMPOUNDS, COMPOSITIONS AND METHODS OF TREATING DISORDERS | Chengdu Anticancer Bioscience Ltd. | HEASLEY, MEGHAN CHRISTINE | 1626 | Final Rejection | Jul 12, 2023 |
| 18272087 | HOMOLOGOUS ADENOVIRAL VACCINATION | Gritstone Bio, Inc. | GRIZER, CASSANDRA SENN | 1672 | Non-Final OA | Jul 12, 2023 |
| 18271954 | TREATMENT OF MYC-DRIVEN CANCERS WITH GSPT1 DEGRADERS | Monte Rosa Therapeutics AG | BRAUN, MADELINE E | 1624 | Non-Final OA | Jul 12, 2023 |
| 18349566 | SKELETAL MUSCLE AUGMENTATION UTILIZING MUSCLE-DERIVED PROGENITOR COMPOSITIONS, AND TREATMENTS THEREOF | UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION | MOLOYE, TITILAYO | 1632 | Non-Final OA | Jul 10, 2023 |
| 18260375 | ENCAPSULATED RNA POLYNUCLEOTIDES AND METHODS OF USE | Elevatebio Technologies, Inc. | PAULUS, ERIN VIRGINIA | 1631 | Non-Final OA | Jul 05, 2023 |
| 18015271 | HYDROGEL-BASED PACKAGING OF 2D MATERIALS-BASED BIOSENSOR DEVICES FOR ANALYTE DETECTION AND DIAGNOSTICS | Grolltex, Inc. | WASHINGTON, BRITNEY NICOLE | 1797 | Non-Final OA | Jul 05, 2023 |
| 18260383 | SIALIDASE-HER2-ANTIBODY FUSION PROTEINS AND METHODS OF USE THEREOF | Palleon Pharmaceuticals Inc. | NICKOL, GARY B | 1643 | Non-Final OA | Jul 05, 2023 |
| 18260378 | SIALIDASE-PD-1-ANTIBODY FUSION PROTEINS AND METHODS OF USE THEREOF | Palleon Pharmaceuticals Inc. | BOWERS, ERIN M | 1653 | Non-Final OA | Jul 05, 2023 |
| 17923411 | Antibodies Targeting CLEC12A and Use Thereof | Dragonfly Therapeutics, Inc. | HUYNH, PHUONG N | 1641 | Non-Final OA | Jul 05, 2023 |
| 18260364 | ANTI-PD-L1 ANTIBODIES AND FUSION PROTEINS THEREOF | Palleon Pharmaceuticals Inc. | ALSOMAIRY, SARAH ABDOALATIF | 1646 | Non-Final OA | Jul 05, 2023 |
| 18345514 | TREATMENT OF GLAUCOMA USING ENDOTHELIN RECEPTOR ANTAGONISTS | Perfuse Therapeutics, Inc. | ANTHOPOLOS, PETER | 1611 | Non-Final OA | Jun 30, 2023 |
| 18216074 | Human Anti-CD27 Antibodies | Janssen Biotech, Inc. | STOICA, ELLY GERALD | 1647 | Non-Final OA | Jun 29, 2023 |
| 18269301 | METHODS OF TREATING MULTIPLE SCLEROSIS | Ascentage Pharma Group Corp Limited | SHIM, DAVID M. | 1626 | Non-Final OA | Jun 23, 2023 |
| 18339310 | THERAPEUTIC USE OF CHARDONNAY SEED PRODUCTS | The United States Of America, AS Represented By The Secretary Of Agriculture | GHALI, ISIS A D | 1611 | Non-Final OA | Jun 22, 2023 |
| 18212371 | SELECTIVE ENRICHMENT | Harbinger Health, Inc. | GOLDBERG, JEANINE ANNE | 1682 | Non-Final OA | Jun 21, 2023 |
| 18258399 | METHOD OF CONTROLLING A JOINT OF AN ORTHOPAEDIC TECHNOLOGY DEVICE AND JOINT OF THIS KIND | Ottobock SE & Co. Kgaa | NERENBERG, RENEE FLORENCIA | 3774 | Non-Final OA | Jun 20, 2023 |
| 18335911 | PUSH-IN SUTURE ANCHOR SYSTEM | Responsive Arthroscopy, Inc. | SHI, KATHERINE MENGLIN | 3771 | Final Rejection | Jun 15, 2023 |
| 18335103 | ALL-SUTURE ANCHOR | Responsive Arthroscopy, Inc. | HOLWERDA, KATHLEEN SONNETT | 3771 | Final Rejection | Jun 14, 2023 |
| 18257045 | FROZEN PLANT-BASED PORTIONED MILK CONCENTRATE AND METHODS OF PREPARATION THEREOF | Daily Harvest, Inc. | AXTELL, ASHLEY | 1792 | Non-Final OA | Jun 12, 2023 |
| 18256836 | BIOACTIVE SUBSTANCE CONJUGATE, PREPARATION METHOD THEREFOR AND USE THEREOF | Medilink Therapeutics (Suzhou) Co., Ltd. | ROGERS, JAMES WILLIAM | 1618 | Non-Final OA | Jun 09, 2023 |
| 18266445 | CCR6 ANTIBODIES | Monash University | BENAVIDES, JENNIFER ANN | 1675 | Non-Final OA | Jun 09, 2023 |
| 18332357 | USE OF SELECTIVE VEGFR2 AND FGFR1 INHIBITORS | Fountain Therapeutics Inc. | KUCKLA, ANNA GRACE | 1626 | Non-Final OA | Jun 09, 2023 |
| 18256907 | METHODS OF PROTEIN ANALYSIS | Calico Life Sciences LLC | WECKER, JENNIFER | 1797 | Non-Final OA | Jun 09, 2023 |
| 18256331 | METHOD FOR ANALYZING USEFUL DATA OF AN ORTHOPEDIC DEVICE | Otto Bock Healthcare Products GmbH | KANAAN, LIZA TONY | 3683 | Final Rejection | Jun 07, 2023 |
| 18330185 | MODULATORS OF THE INTEGRATED STRESS PATHWAY | AbbVie Inc. | RICCI, CRAIG D | 1611 | Non-Final OA | Jun 06, 2023 |
| 18330171 | MODULATORS OF THE INTEGRATED STRESS PATHWAY | AbbVie Inc. | PATEL, SAGAR S | 1626 | Non-Final OA | Jun 06, 2023 |
| 18265341 | HETERODIMERIC IGA FC CONSTRUCTS AND METHODS OF USE THEREOF | Zymeworks, Inc. | MERTZ, PREMA MARIA | 1674 | Non-Final OA | Jun 05, 2023 |
| 18265117 | DEVELOPMENT AND APPLICATION OF T-CELL ENGAGER THERAPEUTIC AGENT | Keymed Biosciences Co.,Ltd | LUNDE, GRACE HENRY | 1641 | Non-Final OA | Jun 02, 2023 |
| 18255539 | COMPOSITIONS AND METHODS OF USE THEREOF | Gritstone Bio, Inc. | JADHAO, SAMADHAN JAISING | 1672 | Non-Final OA | Jun 01, 2023 |
| 18327402 | CLAUDIN 18.2 ANTIBODIES, METHODS OF MAKING THE SAME, AND USES THEREOF | Integral Molecular, Inc. | REN, HONG | 1647 | Non-Final OA | Jun 01, 2023 |
| 18204779 | METHOD FOR THE TREATMENT OF CANCER VIA TUMOR CELL LYSIS AND INTRATUMORAL ADMINISTRATION OF COMBINATIONS OF IMMUNOTHERAPEUTIC INGREDIENTS | Syncromune, Inc. | SOLOMON, JOSHUA BRENDON | 3792 | Non-Final OA | Jun 01, 2023 |
| 18203913 | Controllable Transcription | Cambridge Enterprise Limited (Gb/Gb) | RIGA, MICHAEL ANGELO | 1634 | Non-Final OA | May 31, 2023 |
| 18203919 | Controllable Transcription | Cambridge Enterprise Limited (Gb/Gb) | KONOPKA, CATHERINE ANNE | 1635 | Non-Final OA | May 31, 2023 |
| 18202836 | RSV VACCINES AND METHODS OF ADMINISTERING SAME | Meissa Vaccines, Inc. | PENNINGTON, HALLIE NICOLE | 1671 | Non-Final OA | May 26, 2023 |
| 18321670 | DEVICES AND METHODS FOR THE TREATMENT OF HEART FAILURE | Corvia Medical, Inc. | STEWART, ALVIN J | 3799 | Non-Final OA | May 22, 2023 |
| 18319350 | METHODS OF PREPARING GENE THERAPIES | Bridgebio Services Inc. | PENNINGTON, HALLIE NICOLE | 1671 | Non-Final OA | May 17, 2023 |
| 18316310 | METHODS AND SYSTEMS FOR TRACKING POTENTIAL ACTIVITY OF A CUSTOMER BASED ON LOCATION | Impel It! Inc. | YESILDAG, MEHMET | 3624 | Non-Final OA | May 12, 2023 |
| 18316851 | SYSTEMS AND METHODS FOR TRANSACTION COMMIT AND LOCK RELEASE ATOP PARTITIONED CONSENSUS | Cockroach Labs, Inc. | ADAMS, CHARLES D | 2152 | Final Rejection | May 12, 2023 |
| 18036713 | MK2 ACTIVATING COMPOUNDS FOR USE IN TREATING VASCULAR LEAK AND ENDOTHELIAL BARRIER DISORDERS | Akttyva Therapeutics, Inc. | BELL, SARA ELIZABETH | 1625 | Non-Final OA | May 12, 2023 |
| 18143848 | SYSTEM AND METHOD FOR LASER BASED ENDODONTIC TREATMENT | Convergent Dental, Inc. | HOLTZCLAW, MICHAEL T. | 3796 | Non-Final OA | May 05, 2023 |
| 18308481 | COMPOSITIONS AND METHODS OF GENOMIC MODIFICATION OF CELLS AND USES THEREOF | Arsenal Biosciences, Inc. | YU, DAVID TUYANG | 1635 | Non-Final OA | Apr 27, 2023 |
| 18250347 | RECOMBINANT T-CELL RECEPTORS THAT BIND THE NY-ESO-1 AND/OR LAGE-1A CANCER ANTIGENS | T-Cure Bioscience, Inc. | BRISTOL, LYNN ANNE | 1643 | Non-Final OA | Apr 24, 2023 |
| 18249934 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER | The University of Western Australia | FISCHER, JOSEPH | 1658 | Non-Final OA | Apr 20, 2023 |
| 18304282 | AMPLIFICATION OF NUCLEIC ACIDS | Lumiradx UK Ltd. | BERTAGNA, ANGELA MARIE | 1681 | Non-Final OA | Apr 20, 2023 |
| 18302925 | SYSTEMS AND METHODS FOR EXTERNAL DETECTION OF MISCONFIGURED SYSTEMS | Bitsight Technologies, Inc. | KORSAK, OLEG | 2492 | Final Rejection | Apr 19, 2023 |
| 18032538 | Star Polymer Drug Conjugates | The United States Department of Health and Human Services | LISTVOYB, GREGORY | 1765 | Non-Final OA | Apr 18, 2023 |
| 18301036 | FN3 Domain-siRNA Conjugates with Enzyme Replacement Therapy | Aro Biotherapeutics Company | GIBBS, TERRA C | 1635 | Non-Final OA | Apr 14, 2023 |
| 18248839 | METHODS OF USING SELECTIVE DELIVERY MOLECULES | Avelas Acquisition Corporation | LIU, TRACY | 1614 | Non-Final OA | Apr 12, 2023 |
| 18295991 | TISSUE KALLIKREIN-1 FOR TREATING CHRONIC KIDNEY DISEASE | Diamedica Therapeutics Inc. | BOWERS, ERIN M | 1653 | Final Rejection | Apr 05, 2023 |
| 18128698 | RARE NUCLEIC ACID DETECTION | Harbinger Health, Inc. | WOOLWINE, SAMUEL C | 1681 | Non-Final OA | Mar 30, 2023 |
| 18246783 | METHOD FOR CONTROLLING A PROSTHETIC FOOT | Otto Bock Healthcare Products GmbH | BAHENA, CHRISTIE L. | 3774 | Non-Final OA | Mar 27, 2023 |
| 18126055 | GALECTIN-3 IMMUNOASSAY | BG Medicine, Inc. | GABEL, GAILENE | 1678 | Non-Final OA | Mar 24, 2023 |
| 18027346 | Compositions and Methods of Manufacturing Amphiphilic Block Copolymers that Form Nanoparticles in Situ | Institute Of Macromolecular Chemistry | ZHANG SPIERING, DONGXIU | 1616 | Final Rejection | Mar 20, 2023 |
| 18122527 | METHODS AND COMPOSITIONS FOR ASSESSING ANTIBODY SPECIFICITIES | Serimmune Inc. | JACKSON-TONGUE, LAKIA J | 1645 | Non-Final OA | Mar 16, 2023 |
| 18044943 | ANTIBODIES CONTAINING UNNATURAL AMINO ACIDS AND METHODS OF MAKING AND USING THE SAME | Brickbio, Inc. | HUYNH, PHUONG N | 1641 | Non-Final OA | Mar 10, 2023 |
| 18181386 | CONTROL ELEMENTS FOR TRACKING AND MOVEMENT OF FURNITURE AND INTERIOR ARCHITECTURAL ELEMENTS | Ori Inc. | SHAFAYET, MOHAMMED | 2116 | Final Rejection | Mar 09, 2023 |
| 18025028 | DEVICES, SYSTEMS, AND METHODS FOR SAMPLE TUBE PROCESSING | Selux Diagnostics, Inc. | CASTANEDA, STEVEN RAY | 1797 | Non-Final OA | Mar 07, 2023 |
| 18177847 | METHODS OF TREATING CANCER USING MULTI-SPECIFIC BINDING PROTEINS THAT BIND NKG2D, CD16, AND HER2 | Dragonfly Therapeutics, Inc. | SULLIVAN, DENNIS JOHN | 1642 | Non-Final OA | Mar 03, 2023 |
| 18024149 | Biomarkers for Predicting Multiple Sclerosis Disease Progression | Octave Bioscience, Inc. | BOWERS, ERIN M | 1653 | Non-Final OA | Mar 01, 2023 |
| 18023668 | Storage Stable Films Comprising Fibrin and/or Fibrinogen | Octapharma AG | MATTISON, LORI K | 1619 | Final Rejection | Feb 27, 2023 |
| 18023298 | MODULATORS OF MYC FAMILY PROTO-ONCOGENE PROTEIN | Nalo Therapeutics | SAMSELL, RILLA MARIE | 1624 | Non-Final OA | Feb 24, 2023 |
| 18022614 | SENSORS FOR UNBIASED PROTEOMIC STUDIES, METHOD OF MANUFACTURE AND USE THEREOF | Nanomosaic Inc. | HUANG, MICKEY NMN | 1758 | Non-Final OA | Feb 22, 2023 |
| 18022252 | METHODS OF NEUROPROTECTION AND USES THEREOF | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION | AULAKH, CHARANJIT | 1621 | Final Rejection | Feb 20, 2023 |
| 18022062 | NOVEL 5'CAP ANALOG HAVING CAP2 STRUCTURE AND PREPARATION METHOD THEREFOR | Shenzhen Rhegen Biotechnology Co., Ltd. | LEWIS, PATRICK T | 1691 | Non-Final OA | Feb 17, 2023 |
| 18111511 | THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE | Servier Pharmaceuticals LLC | KOMATSU, LI N | 1658 | Non-Final OA | Feb 17, 2023 |
| 18021283 | TEST STRIP HOLDER | Luna Pharmaceuticals, Inc. D/B/A Premma Wellness | HYUN, PAUL SANG HWA | 1796 | Non-Final OA | Feb 14, 2023 |
| 18166769 | PHARMACEUTICAL FORMULATIONS AND THERAPEUTIC USES OF MULTI-SPECIFIC BINDING PROTEINS THAT BIND EGFR, NKG2D, AND CD16 | Dragonfly Therapeutics, Inc. | CHASE, CAROL ANN | 1646 | Non-Final OA | Feb 09, 2023 |
| 18166938 | METHODS AND COMPOSITIONS FOR ENHANCING THE POTENCY OF SUPERANTIGEN MEDIATED CANCER IMMUNOTHERAPY | Neotx Therapeutics Ltd. | BRISTOL, LYNN ANNE | 1643 | Final Rejection | Feb 09, 2023 |
| 18166420 | VACCINE | Treos Bio Limited | DUFFY, BRADLEY | 1643 | Non-Final OA | Feb 08, 2023 |
| 18163196 | CAPTURE OF NUCLEIC ACIDS USING A NUCLEIC ACID-GUIDED NUCLEASE-BASED SYSTEM | Jumpcode Genomics, Inc. | BERTAGNA, ANGELA MARIE | 1681 | Non-Final OA | Feb 01, 2023 |
| 18006494 | COMPOSITIONS AND METHODS FOR TREATING NON-ALCOHOLIC STEATOHEPATITIS | Ascentage Pharma Group Corp Limited | BARSKY, JARED | 1628 | Final Rejection | Jan 23, 2023 |
| 18017319 | FUSION PROTEINS COMPRISING A LIGAND-RECEPTOR PAIR AND A BIOLOGICALLY FUNCTIONAL PROTEIN | Zymeworks, Inc. | LUNDE, GRACE HENRY | 1641 | Non-Final OA | Jan 20, 2023 |
| 18156687 | Pain Medicine Combination and Uses Thereof | Mindlab, LLC | CHONG, YONG SOO | 1623 | Non-Final OA | Jan 19, 2023 |
| 18016829 | METHOD FOR CONTROLLING A PROSTHESIS OR ORTHESIS | Otto Bock Healthcare Products GmbH | SPENCER, MAXIMILIAN TOBIAS | 3774 | Final Rejection | Jan 18, 2023 |
| 18016827 | ORTHOPAEDIC JOINT DEVICE | Otto Bock Healthcare Products GmbH | BAHENA, CHRISTIE L. | 3774 | Final Rejection | Jan 18, 2023 |
| 18016838 | METHOD FOR CONTROLLING A PROSTHESIS OR ORTHOSIS | Otto Bock Healthcare Products GmbH | BAHENA, CHRISTIE L. | 3774 | Non-Final OA | Jan 18, 2023 |
| 18016831 | METHOD FOR CONTROLLING A PROSTHESIS OR ORTHESIS | Otto Bock Healthcare Products GmbH | SPENCER, MAXIMILIAN TOBIAS | 3774 | Final Rejection | Jan 18, 2023 |
| 18005012 | COMBINATION THERAPY FOR TREATING ABNORMAL CELL GROWTH | Verastem, Inc. | HERNANDEZ, JACKSON J | 1627 | Final Rejection | Jan 10, 2023 |
| 18015532 | INFLAMMATORY DISEASE TREATMENT USING ANTI-TISSUE FACTOR ANTIBODIES | Iconic Therapeutics LLC | HOWARD, ZACHARY C | 1674 | Non-Final OA | Jan 10, 2023 |
| 18089372 | SYSTEM AND METHOD FOR LASER BASED WHITENING TREATMENT OF HARD TISSUE | Convergent Dental, Inc. | BELK, SHANNEL NICOLE | 3772 | Non-Final OA | Dec 27, 2022 |
| 18003234 | RECOMBINANT SIALIDASES WITH REDUCED PROTEASE SENSITIVITY, SIALIDASE FUSION PROTEINS, AND METHODS OF USING THE SAME | Palleon Pharmaceuticals Inc. | GODDARD, LAURA B | 1642 | Non-Final OA | Dec 23, 2022 |
| 18003308 | PROTEINS BINDING NKG2D, CD16 AND EGFR | Dragonfly Therapeutics, Inc. | BERHANE, SELAM | 1675 | Non-Final OA | Dec 23, 2022 |
| 18145772 | SARS-COV-2 SERUM ANTIBODY PROFILING | Serimmune Inc. | ZOU, NIANXIANG | 1671 | Non-Final OA | Dec 22, 2022 |
| 18085792 | THERAPEUTIC COMPOSITIONS, COMBINATIONS, AND METHODS OF USE | Verastem, Inc. | JAVANMARD, SAHAR | 1622 | Non-Final OA | Dec 21, 2022 |
| 18065223 | ANTIGEN-BINDING PROTEINS TARGETING SHARED ANTIGENS | Gritstone Bio, Inc. | YAO, LEI | 1642 | Non-Final OA | Dec 13, 2022 |
| 18078240 | INTERTUMORAL HOMOGENEITY DETERMINED BY MiCK ASSAY | Pierian Biosciences, LLC | BAEK, JONGHWAN NMN | 1618 | Non-Final OA | Dec 09, 2022 |
| 18007680 | BISPECIFIC ANTIBODY-DRUG CONJUGATES TARGETING EGFR AND MUC1 AND USES THEREOF | Merck Patent GmbH | STONEBRAKER, ALYSSA RAE | 1642 | Non-Final OA | Dec 01, 2022 |
| 18000486 | ANTIBODIES TARGETING A COMPLEX COMPRISING NON-CLASSICAL HLA-I AND NEOANTIGEN AND THEIR METHODS OF USE | Boehringer Ingelheim International Gmgh | STONEBRAKER, ALYSSA RAE | 1642 | Non-Final OA | Dec 01, 2022 |
| 18007608 | Electronic Health Record (EHR)-Based Classifier for Acute Respiratory Distress Syndrome (ARDS) Subtyping | Endpoint Health Inc. | BALAJ, ANTHONY MICHAEL | 3682 | Final Rejection | Dec 01, 2022 |
| 17928708 | TREATMENT OF NEUROLOGICAL DISEASES USING MODULATORS OF GENE TRANSCRIPTS | Quralis Corporation | SHIN, DANA H | 1635 | Non-Final OA | Nov 30, 2022 |
| 17923421 | ENPP1 INHIBITORS AND METHODS OF MODULATING IMMUNE RESPONSE | Angarus Therapeutics, Inc. | JARRELL, NOBLE E | 1699 | Non-Final OA | Nov 22, 2022 |
| 17985556 | Continuous Administration of Dopa Decarboxylase Inhibitors and Compositions for Same | Neuroderm, Ltd. | WEBB, WALTER E | 1612 | Non-Final OA | Nov 11, 2022 |
| 17924299 | SYSTEMS AND METHODS FOR IMPROVED OPERATION OF MOVEABLE ROBOTIC ELEMENTS | Ori Inc. | GEDEON, DEBORAH TALITHA | 3673 | Final Rejection | Nov 09, 2022 |
| 17922734 | AN IMPROVED PROCESS OF PURIFICATION OF PROTEIN | Kashiv Biosciences, LLC | MCDERMOTT, JEANNIE | 1777 | Final Rejection | Nov 01, 2022 |
| 17921509 | METHODS OF TREATING ABNORMAL CELL GROWTH | Verastem, Inc. | HIRAKIS, SOPHIA P | 1623 | Non-Final OA | Oct 26, 2022 |
| 17921257 | METHODS FOR SYNTHESIZING N-(PHENYLSULFONYL)BENZAMIDE COMPOUNDS AND INTERMEDIATES THEREOF | Ascentage Pharma Group Corp Limited | HEITMEIER, KENDALL NICOLE | 1621 | Non-Final OA | Oct 25, 2022 |
| 18048407 | CAPPING COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF | Gritstone Bio, Inc. | LEE, HOI YAN NMN | 1693 | Non-Final OA | Oct 20, 2022 |
| 17996505 | COMPOSITIONS OF SMAD7 ANTISENSE OLIGONUCLEOTIDES (ASO) AND METHODS OF USING THE SAME | Nogra Pharma Limited | VANHORN, ABIGAIL LOUISE | 1636 | Final Rejection | Oct 18, 2022 |
| 17919109 | ANTIBODY CONSTRUCTS BINDING 4-1BB AND FOLATE RECEPTOR ALPHA AND USES THEREOF | Zymeworks, Inc. | SWARTWOUT, BRIANNA KENDALL | 1644 | Non-Final OA | Oct 14, 2022 |
| 17918185 | ATTENUATED-BACKGROUND MICROBIOLOGICAL NUTRIENT MEDIA AND METHODS OF USING THE SAME | Rapid Micro Biosystems, Inc. | AFREMOVA, VERA | 1653 | Final Rejection | Oct 11, 2022 |
| 17995657 | SYSTEM FOR DELIVERING TARGETED CONTENT WITH CARE PREFERENCE SUGGESTIONS | Texas Medical Center | KANAAN, LIZA TONY | 3683 | Final Rejection | Oct 06, 2022 |
| 17995299 | CORONAVIRUS VACCINE | Peptc Vaccines Limited | DIBRINO, MARIANNE | 1641 | Non-Final OA | Sep 30, 2022 |
| 17633672 | AMINOACYL-TRNA SYNTHETASES AND CELL LINES FOR SITE-SPECIFIC INCORPORATION OF UNNATURAL AMINO ACIDS | Brickbio, Inc. | RYAN, DOUGLAS CHARLES | 1635 | Non-Final OA | Sep 29, 2022 |
| 17934950 | PROCESS FOR PREPARATION OF STABLE PROTEIN SOLUTION | Kashiv Biosciences, LLC | COOK, LISA V | 1642 | Final Rejection | Sep 23, 2022 |
| 17914261 | MASKED IL12 FUSION PROTEINS AND METHODS OF USE THEREOF | Zymeworks, Inc. | PATTERSON, SARAH COOPER | 1675 | Non-Final OA | Sep 23, 2022 |
| 17906857 | FGFR3-TARGETED RADIOIMMUNOCONJUGATES AND USES THEREOF | Fusion Pharmaceuticals Inc. | BUTTICE, AUDREY L | 1647 | Non-Final OA | Sep 20, 2022 |
| 17909212 | METHODS AND COMPOSITIONS FOR TREATING CANCER WITH IMMUNE CELLS | Neotx Therapeutics Ltd. | BEHARRY, ZANNA MARIA | 1632 | Non-Final OA | Sep 02, 2022 |
| 17929609 | COMPOSITIONS AND METHODS FOR DIAGNOSING, PREVENTING, AND TREATING AMYOTROPHIC LATERAL SCLEROSIS IN PATIENTS WITH HYPOFUNCTIONAL ANTI-TRYPSIN ACTIVITY | Motor Life Sciences, LLC | KENYON, JOHN S | 1625 | Non-Final OA | Sep 02, 2022 |
| 17800958 | METHODS AND COMPOSITIONS FOR MODULATING ARGININE LEVELS IN IMMUNE CELLS | Sky Perfect International Limited | DHAR, MATASHA | 1632 | Non-Final OA | Aug 19, 2022 |
| 17904038 | BIO-THERAPEUTICS FOR DETECTION, DIAGNOSIS AND TREATMENT OF DISEASES ASSOCIATED WITH MUCOSAL BLEEDING | Tenza, Inc. | JOHANSEN, PETER N. | 1644 | Non-Final OA | Aug 11, 2022 |
| 17879923 | 6-MEMBERED AZA-HETEROCYCLIC CONTAINING DELTA-OPIOID RECEPTOR MODULATING COMPOUNDS, METHODS OF USING AND MAKING THE SAME | Trevena, Inc. | JAVANMARD, SAHAR | 1622 | Non-Final OA | Aug 03, 2022 |
| 17875811 | PHARMACEUTICAL COMPOSITION COMPRISING THIRD GENERATION SMALL MOLECULE EGFR INHIBITOR AND PREPARATION METHOD THEREOF | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | PHAN, DOAN THI-THUC | 1613 | Non-Final OA | Jul 28, 2022 |
| 17795402 | COMBINATION THERAPY FOR TREATING ABNORMAL CELL GROWTH | Verastem, Inc. | SANCHEZ, JUSTIN CHRISTOPHER | 1622 | Non-Final OA | Jul 26, 2022 |
| 17814824 | STING AGONIST COMBINATION TREATMENTS WITH CYTOKINES | The Board Of Regents Of The University Of Texas System | GURLEY, JAMI MICHELLE | 1647 | Non-Final OA | Jul 25, 2022 |
| 17861088 | CELL-FREE DNA MONITORING | Gritstone Bio, Inc. | SMITH, EMILIE ALINE | 1686 | Non-Final OA | Jul 08, 2022 |
| 17788009 | GUT MICROBIOTA-RELATED METHODS FOR TREATING DEMENTIA AND AGE-DEPENDENT COGNITIVE DECLINE | Albert-Ludwigs-Universität Freiburg | ALABI, OYELEYE A | 1797 | Non-Final OA | Jun 22, 2022 |
| 17787828 | Protein Tyrosine Phosphatase Degraders and Methods of Use Thereof | AbbVie Inc. | VALLE, ERNESTO | 1623 | Non-Final OA | Jun 21, 2022 |
| 17787483 | METHODS AND COMPOSITIONS FOR INDUCING APOPTOSIS IN CANCER STEM CELLS | VIRGINIA COMMONWEALTH UNIVERSITY | DABKOWSKI, ERINNE R | 1654 | Non-Final OA | Jun 20, 2022 |
| 17786383 | APPARATUS AND METHOD FOR SOLID PHASE EXTRACTION | GE Healthcare Limited | SIEFKE, SAMUEL P | 1758 | Final Rejection | Jun 16, 2022 |
| 17785385 | METHODS, KITS AND COMPOSITIONS FOR REDUCING CARDIOTOXICITY ASSOCIATED WITH CANCER THERAPIES | Richard G. Pestell | DENT, ALANA HARRIS | 1643 | Non-Final OA | Jun 14, 2022 |
| 17839786 | NON-NANOPARTICULATE APPLICATION FORMS OF MACROLIDES | Nucleus Medical GmbH | LEE, SIN J | 1613 | Final Rejection | Jun 14, 2022 |
| 17837891 | COMPOSITIONS AND METHODS FOR TREATMENT OF ABNORMAL CELL GROWTH | Pfizer, Inc. | PEEBLES, KATHERINE | 1617 | Non-Final OA | Jun 10, 2022 |
| 17838114 | DURABLE VACCINATION | Gritstone Bio, Inc. | CHEN, STACY BROWN | 1672 | Non-Final OA | Jun 10, 2022 |
| 17836304 | Nucleic Acid Carriers And Therapeutic Methods Of Use | Code Biotherapeutics, Inc. | SU-TOBON, QIWEN NMN | 1636 | Non-Final OA | Jun 09, 2022 |
| 17824426 | NEURODEGENERATION AND CHIROGRAPHIC PERFORMANCE MONITORING | Huma Therapeutics Ltd. | BAKER, IRENE H | 2152 | Non-Final OA | May 25, 2022 |
| 17777850 | METHODS FOR TREATMENT OF CANCERS | Fusion Pharmaceuticals Inc. | VU, JAKE MINH | 1618 | Non-Final OA | May 18, 2022 |
| 17744354 | ANTIGEN-BINDING PROTEINS TARGETING SHARED NEOANTIGENS | Gritstone Bio, Inc. | LEE, YIE CHIA | 1642 | Non-Final OA | May 13, 2022 |
| 17740830 | CUSTOMIZED HYBRID BONE-IMPLANT GRAFTS | New York Stem Cell Foundation, Inc. | TREVINO III, JOSE HERNANDEZ | 3774 | Non-Final OA | May 10, 2022 |
| 17736738 | SHARED NEOANTIGEN VACCINES | Gritstone Bio, Inc. | HILL, KEVIN KAI | 1638 | Non-Final OA | May 04, 2022 |
| 17724876 | GARMENT FOR TREATMENT OF INCONTINENCE | Attn: Grace, Inc. | HAN, SETH | 3781 | Final Rejection | Apr 20, 2022 |
| 17769257 | ANTIBODIES TARGETING FLT3 AND USE THEREOF | Dragonfly Therapeutics, Inc. | WEHBE, ANNE MARIE SABRINA | 1634 | Non-Final OA | Apr 14, 2022 |
| 17769160 | PROTEINS BINDING NKG2D, CD16 AND FLT3 | Dragonfly Therapeutics, Inc. | GUSTILO, ESTELLA M | 1646 | Final Rejection | Apr 14, 2022 |
| 17768922 | METHODS OF TREATING CANCER WITH A STING AGONIST | The Board Of Regents Of The University Of Texas System | CHO, DAVID H | 1693 | Final Rejection | Apr 14, 2022 |
| 17720625 | PHARMACEUTICAL COMPOSITIONS COMPRISING GRANULATED BEMPEDOIC ACID | Esperion Therapeutics, Inc. | GREENE, IVAN A | 1619 | Final Rejection | Apr 14, 2022 |
| 17658817 | SURGICAL FASTENERS, TOOLS, AND METHODS | Arthrosurface, Inc. | RAMANA, ANURADHA | 3775 | Non-Final OA | Apr 11, 2022 |
| 17767687 | Chimeric Cytokine Receptors | UVIC INDUSTRY PARTNERSHIPS INC. | GRABER, JAMES J | 1631 | Non-Final OA | Apr 08, 2022 |
| 17767682 | Modified Extracellular Domain of Granulocyte Colony-Stimulating Factor Receptor (G-CSFR) and Cytokines Binding Same | UVIC INDUSTRY PARTNERSHIPS INC. | JUEDES, AMY E | 1644 | Final Rejection | Apr 08, 2022 |
| 17766439 | IMAGING SYSTEM AND METHOD OF USE THEREOF | New York Stem Cell Foundation, Inc. | PARK, EDWARD | 2675 | Non-Final OA | Apr 04, 2022 |
| 17766018 | Biomarker Panels for Guiding Dysregulated Host Response Therapy | Endpoint Health Inc. | BICKHAM, DAWN MARIE | 1685 | Non-Final OA | Apr 01, 2022 |
| 17766017 | Improved Variant Caller Using Single-Cell Analysis | Mission Bio, Inc. | DHARITHREESAN, NIDHI | 1686 | Non-Final OA | Apr 01, 2022 |
| 17639401 | METHODS OF TREATING EPILEPSY USING THE SAME | Trevena, Inc. | NESTOR, DONNA MICHELLE | 1627 | Non-Final OA | Mar 01, 2022 |
| 17682314 | FORMULATION OF HIGHLY CONCENTRATED PHARMACOLOGICALLY ACTIVE ANTIBODY | Kashiv Biosciences, LLC | TAYLOR, LIA ELAN | 1641 | Non-Final OA | Feb 28, 2022 |
| 17635751 | ORTHOPAEDIC DEVICE AND ENERGY STORAGE DEVICE | Ottobock SE & Co. Kgaa | DUDDEN, TERESA MARIE | 3774 | Non-Final OA | Feb 16, 2022 |
| 17635459 | PIMAVANSERIN FOR TREATING NEURODEGENERATIVE DISEASES | Acadia Pharmaceuticals Inc. | ISMAIL, REHANA | 1625 | Non-Final OA | Feb 15, 2022 |
| 17631588 | MULTI-VALENT AND MULTI-SPECIFIC NANOPARTICLE PLATFORMS AND METHODS | The Governing Council of the University of Toronto | HOPKINS, SAMANTHA LAKE | 1641 | Final Rejection | Jan 31, 2022 |
| 17586238 | ULINASTATIN POLYPEPTIDES FOR TREATING DISEASES | Diamedica Usa Inc. | HADDAD, MAHER M | 1641 | Final Rejection | Jan 27, 2022 |
| 17628189 | LYOPHILIZED ANTIBODY FORMULATION | Ichnos Sciences SA | KIM, YUNSOO | 1641 | Non-Final OA | Jan 18, 2022 |
| 17574790 | Methods and Compositions for Two-Stage Microbubble Delivery of Active Agents | VIRGINIA COMMONWEALTH UNIVERSITY | SCHLIENTZ, LEAH H | 1618 | Non-Final OA | Jan 13, 2022 |
| 17624121 | RECOMBINANT HUMAN SIALIDASES, SIALIDASE FUSION PROTEINS, AND METHODS OF USING THE SAME | Palleon Pharmaceuticals Inc. | BORGEEST, CHRISTINA M | 1675 | Non-Final OA | Dec 30, 2021 |
| 17624123 | RECOMBINANT SIALIDASES AND METHODS OF USING THE SAME | Palleon Pharmaceuticals Inc. | WEHBE, ANNE MARIE SABRINA | 1634 | Non-Final OA | Dec 30, 2021 |
| 17622438 | APPARATUSES AND WEARABLE GARMENTS INCLUDING ELECTRICAL SOURCES AND CIRCUIT ELEMENTS | Armington Studios Inc. | SMITH, KAITLYN ELIZABETH | 3794 | Non-Final OA | Dec 23, 2021 |
| 17619036 | COMPOSITIONS AND METHODS FOR BIOLOGICAL DELIVERY VEHICLES | Dnalite Therapeutics, Inc. | MITCHELL, EDWIN COLEMAN | 1619 | Non-Final OA | Dec 14, 2021 |
| 17604227 | Compositions and Methods of Manufacturing Star Polymers for Ligand Display and/or Drug Delivery | The United States Department of Health and Human Services | KAMM, JUDITH MARIE | 1611 | Final Rejection | Oct 15, 2021 |
| 17498290 | ISOLATION OF TARGET NUCLEIC ACIDS | Harbinger Health, Inc. | MUMMERT, STEPHANIE KANE | 1681 | Non-Final OA | Oct 11, 2021 |
| 17495266 | CANCER-SPECIFIC MOLECULES AND METHODS OF USE THEREOF | Envisagenics, Inc. | DACE DENITO, ALEXANDRA GERALDINE | 1636 | Final Rejection | Oct 06, 2021 |
| 17484604 | DISCOVERY ENGINE FOR INTERACTIVE VIDEOS | Jbf Interlude 2009 Ltd. | KANG, TIMOTHY J | 3689 | Final Rejection | Sep 24, 2021 |
| 17440067 | PEPTIDE-INDUCED NK CELL ACTIVATION | UNIVERSITY OF SOUTHAMPTON | DICKINSON, PAUL W | 1618 | Non-Final OA | Sep 16, 2021 |
| 17434666 | Compositions and Methods for Treating Oculopharyngeal Muscular Dystrophy (OPMD) | Benitec Ip Holdings Inc. | WHITEMAN, BRIAN A | 1636 | Non-Final OA | Aug 27, 2021 |
| 17431057 | AN APPARATUS FOR ACQUIRING SIGNALS FROM A PREGNANT SUBJECT | Biorithm Pte. Ltd. | STEINBERG, AMANDA L | 3792 | Final Rejection | Aug 13, 2021 |
| 17426141 | SURVIVAL-TARGETING CHIMERIC (SURTAC) MOLECULES | Entact Bio Limited | YAO, LEI | 1642 | Non-Final OA | Jul 28, 2021 |
| 17296012 | HIGH COMPLEXITY SYNTHETIC GUT BACTERIAL COMMUNITIES | The Board Of Trustees Of The Leland Stanford Junior University | SINGH, SATYENDRA K | 1657 | Final Rejection | May 21, 2021 |
| 17282447 | AROMATIC RING SUBSTITUTED AMPHIPHILIC POLYMERS AS DRUG DELIVERY SYSTEMS | The United States Department of Health and Human Services | WESTERBERG, NISSA M | 1618 | Final Rejection | Apr 02, 2021 |
| 17157043 | Dynamically Changing Promotions Displayed on a Mobile Device and Measuring The Benefit Thereof | UPSIDE SERVICES, INC. | OSMAN BILAL AHMED, AFAF | 3622 | Non-Final OA | Jan 25, 2021 |
| 17058335 | MULTI-SPECIFIC BINDING PROTEINS AND IMPROVEMENTS THEREON | Dragonfly Therapeutics, Inc. | YAO, LEI | 1642 | Final Rejection | Nov 24, 2020 |
| 17054400 | ARTIFICIAL FOOT | Ottobock SE & Co. Kgaa | SPENCER, MAXIMILIAN TOBIAS | 3774 | Final Rejection | Nov 10, 2020 |
| 16975823 | Neoantigen Identification with Pan-Allele Models | Gritstone Bio,Inc. | BAILEY, STEVEN WILLIAM | 1687 | Non-Final OA | Aug 26, 2020 |
| 16990291 | PARALLEL IMPLEMENTATIONS OF FRAME FILTERS WITH RECURSIVE TRANSFER FUNCTIONS | The MathWorks, Inc. | SINGH, AMNEET | 2633 | Final Rejection | Aug 11, 2020 |
| 16615261 | PROTEINS BINDING NKG2D, CD16 AND A TUMOR-ASSOCIATED ANTIGEN | Dragonfly Therapeutics, Inc. | JOHANSEN, PETER N. | 1644 | Non-Final OA | Nov 20, 2019 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial